Early gene mapping after deep brain stimulation in a rat model of tardive dyskinesia: Comparison with transient local inactivation

European Neuropsychopharmacology

Volumn 22, Issue 7, 2012, Pages 506-517

  Creed, Meaghan C ^a,b   Hamani, Clement ^b,c   Nobrega, José N ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Basal ganglia; Egr 1; EGR1; Entopeduncular nucleus; Globus pallidus; Haloperidol; Krox 2; Muscimol; NGFI A; Subthalamic nucleus; Tis8; Vacuous chewing; Zenk; Zif268

Indexed keywords

HALOPERIDOL DECANOATE; MUSCIMOL; PROTEIN; UNCLASSIFIED DRUG; ZIF268 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DEPTH STIMULATION; CAUDATE NUCLEUS; CONTROLLED STUDY; ENTOPEDUNCULAR NUCLEUS; GENE MAPPING; GLOBUS PALLIDUS; MALE; MASTICATION; MOTOR CORTEX; NONHUMAN; PRIORITY JOURNAL; PUTAMEN; RAT; SUBSTANTIA NIGRA PARS COMPACTA; SUBSTANTIA NIGRA PARS RETICULATA; SUBTHALAMUS; TARDIVE DYSKINESIA; THALAMUS; VACUOUS CHEWING MOVEMENT;

ANALYSIS OF VARIANCE; ANIMALS; ANTIPSYCHOTIC AGENTS; DEEP BRAIN STIMULATION; EARLY GROWTH RESPONSE PROTEIN 1; ENTOPEDUNCULAR NUCLEUS; GABA-A RECEPTOR AGONISTS; GENE EXPRESSION REGULATION; GLOBUS PALLIDUS; HALOPERIDOL; MALE; MASTICATION; MOVEMENT DISORDERS; MUSCIMOL; RATS; RATS, SPRAGUE-DAWLEY; SUBTHALAMIC NUCLEUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84861481533     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2011.11.004     Document Type: Article

References (64)

1. Adachi K., Hasegawa M., Ikeda H., Sato M., Koshikawa N., Cools A.R. The superior colliculus contains a discrete region involved in the control of jaw movements: role of GABAA receptors. Eur. J. Pharmacol. 2003, 464(2-3):147-154.
2. Aziz T.Z., Peggs D., Sambrook M.A., Crossman A.R. Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate. Mov. Disord. 1991, 6(4):288-292.
3. Benazzouz A., Hallett M. Mechanism of action of deep brain stimulation. Neurology 2000, 55(12 Suppl. 6):S13-S16.
4. Benjamini Y., Rochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 1995, 57(1):289-300.
5. Benjamini Y., Drai D., Elmer G., Kafkafi N., Golani I. Controlling the false discovery rate in behavior genetics research. Behav. Brain Res. 2001, 125(1-2):279-284.
6. Blomstedt P., Fytagoridis A., Tisch S. Deep brain stimulation of the posterior subthalamic area in the treatment of tremor. Acta Neurochir. (Wien) 2009, 151(1):31-36.
7. Bozon B., Davis S., Laroche S. Regulated transcription of the immediate-early gene Zif268: mechanisms and gene dosage-dependent function in synaptic plasticity and memory formation. Hippocampus 2002, 12(5):570-577.
8. Burkhardt J.M., Constantinidis C., Anstrom K.K., Roberts D.C., Woodward D.J. Synchronous oscillations and phase reorganization in the basal ganglia during akinesia induced by high-dose haloperidol. Eur. J. Neurosci. 2007, 26(7):1912-1924.
9. Cacciola F., Farah J.O., Eldridge P.R., Byrne P., Varma T.K. Bilateral deep brain stimulation for cervical dystonia: long-term outcome in a series of 10 patients. Neurosurgery 2010, 67(4):957-963.
10. Casey D.E. Tardive dyskinesia: reversible and irreversible. Psychopharmacology Suppl. 1985, 2:88-97.
11. Casey D.E. Pathophysiology of antipsychotic drug-induced movement disorders. J. Clin. Psychiatry 2004, 65(Suppl. 9):25-28.
12. Ceballos-Baumann A.O., Boecker H., Bartenstein P., von Falkenhayn I., Riescher H., Conrad B., et al. A positron emission tomographic study of subthalamic nucleus stimulation in Parkinson disease: enhanced movement-related activity of motor-association cortex and decreased motor cortex resting activity. Arch. Neurol. 1999, 56(8):997-1003.
13. Chaudhuri A. Neural activity mapping with inducible transcription factors. Neuroreport 1997, 8(16):v-ix.
14. Chaudhuri A., Zangenehpour S., Rahbar-Dehgan F., Ye F. Molecular maps of neural activity and quiescence. Acta Neurobiol. Exp. (Wars) 2000, 60(3):403-410.
15. Chin G.D., Hutchison W.D. Effects of cobalt and bicuculline on focal microstimulation of rat pallidal neurons in vivo. Brain Stimul. 2008, 1(3):134-150.
16. Cilia R., Marotta G., Landi A., Isaias I.U., Mariani C.B., Vergani F., et al. Clinical and cerebral activity changes induced by subthalamic nucleus stimulation in advanced Parkinson's disease: a prospective case-control study. Clin. Neurol. Neurosurg. 2009, 111(2):140-146.
17. Cole A.J., Saffen D.W., Baraban J.M., Worley P.F. Rapid increase of an immediate early gene messenger RNA in hippocampal neurons by synaptic NMDA receptor activation. Nature 1989, 340(6233):474-476.
18. Creed M., Hamani C., Nobrega J.N. Deep brain stimulation of the subthalamic or entopeduncular nucleus attenuates vacuous chewing movements in a rodent model of tardive dyskinesia. Eur. Neuropsychopharmacol. 2011, 21(5):393-400.
19. Damier P., Thobois S., Witjas T., Cuny E., Derost P., Raoul S., et al. Bilateral deep brain stimulation of the globus pallidus to treat tardive dyskinesia. Arch. Gen. Psychiatry 2007, 64(2):170-176.
20. Degos B., Deniau J.M., Thierry A.M., Glowinski J., Pezard L., Maurice N. Neuroleptic-induced catalepsy: electrophysiological mechanisms of functional recovery induced by high-frequency stimulation of the subthalamic nucleus. J. Neurosci. 2005, 25(33):7687-7696.
21. Dostrovsky J.O., Levy R., Wu J.P., Hutchison W.D., Tasker R.R., Lozano A.M. Microstimulation-induced inhibition of neuronal firing in human globus pallidus. J. Neurophysiol. 2000, 84(1):570-574.
22. Elble R.J. Tremor: clinical features, pathophysiology, and treatment. Neurol. Clin. 2009, 27(3):679-695. (v-vi).
23. Eltahawy H.A., Feinstein A., Khan F., Saint-Cyr J., Lang A.E., Lozano A.M. Bilateral globus pallidus internus deep brain stimulation in tardive dyskinesia: a case report. Mov. Disord. 2004, 19(8):969-972.
24. Farivar R., Zangenehpour S., Chaudhuri A. Cellular-resolution activity mapping of the brain using immediate-early gene expression. Front. Biosci. 2004, 9:104-109.
25. Fukuda M., Mentis M.J., Ma Y., Dhawan V., Antonini A., Lang A.E., et al. Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: a PET study of resting-state glucose metabolism. Brain 2001, 124(Pt. 8):1601-1609.
26. Grill W.M., Snyder A.N., Miocinovic S. Deep brain stimulation creates an informational lesion of the stimulated nucleus. Neuroreport 2004, 15(7):1137-1140.
27. Haag M. Essential fatty acids and the brain. Can. J. Psychiatry 2003, 48:195-203.
28. Hamani C., Saint-Cyr J.A., Fraser J., Kaplitt M., Lozano A.M. The subthalamic nucleus in the context of movement disorders. Brain 2004, 127(Pt. 1):4-20.
29. Hamann M., Sander S.E., Kreil A., Richter A. Effects of pharmacological entopeduncular manipulations on idiopathic dystonia in the dt (sz) mutant hamster. J. Neural Transm. 2010, 117(6):747-757.
30. Harnack D., Hamann M., Meissner W., Morgenstern R., Kupsch A., Richter A. High-frequency stimulation of the entopeduncular nucleus improves dystonia in dtsz hamsters. Neuroreport 2004, 15(9):1391-1393.
31. Khiat A., Kuznetsov Y., Blanchet P.J., Boulanger Y. Diffusion-weighted imaging and magnetization transfer imaging of tardive and edentulous orodyskinesia. Mov. Disord. 2008, 23(9):1281-1285.
32. Lafreniere-Roula M., Kim E., Hutchison W.D., Lozano A.M., Hodaie M., Dostrovsky J.O. High-frequency microstimulation in human globus pallidus and substantia nigra. Exp. Brain Res. 2010, 205(2):251-261.
33. Le Jeune F., Peron J., Grandjean D., Drapier S., Haegelen C., Garin E., et al. Subthalamic nucleus stimulation affects limbic and associative circuits: a PET study. Eur. J. Nucl. Med. Mol. Imaging 2010, 37(8):1512-1520.
34. Lee J.I., Verhagen Metman L., Ohara S., Dougherty P.M., Kim J.H., Lenz F.A. Internal pallidal neuronal activity during mild drug-related dyskinesias in Parkinson's disease: decreased firing rates and altered firing patterns. J. Neurophysiol. 2007, 97(4):2627-2641.
35. Lenders M.W., Buschman H.P., Vergouwen M.D., Steur E.N., Kolling P., Hariz M. Long term results of unilateral posteroventral pallidotomy for antipsychotic drug induced tardive dyskinesia. J. Neurol. Neurosurg. Psychiatry 2005, 76(7):1039.
36. Levy R., Lang A.E., Dostrovsky J.O., Pahapill P., Romas J., Saint-Cyr J., et al. Lidocaine and muscimol microinjections in subthalamic nucleus reverse Parkinsonian symptoms. Brain 2001, 124(Pt. 10):2105-2118.
37. Lubarr N., Bressman S. Treatment of generalized dystonia. Curr. Treat. Options. Neurol. 2011, 13(3):274-289.
38. MacGibbon G.A., Lawlor P.A., Bravo R., Dragunow M. Clozapine and haloperidol produce a differential pattern of immediate early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja. Brain Res. Mol. Brain Res. 1994, 23(1-2):21-32.
39. Mehta A., Chesselet M. Effect of GABA(A) receptor stimulation in the subthalamic nucleus on motor deficits induced by nigrostriatal lesions in the rat. Exp. Neurol. 2005, 193(1):110-117.
40. Mehta A., Menalled L., Chesselet M. Behavioral responses to injections of muscimol into the subthalamic nucleus: temporal changes after nigrostriatal lesions. Neuroscience 2005, 131(3):769-778.
41. Moro E., Lozano A.M., Pollak P., Agid Y., Rehncrona S., Volkmann J., et al. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov. Disord. 2010, 25(5):578-586.
42. Nambu A., Tokuno H., Takada M. Functional significance of the cortico-subthalamo-pallidal 'hyperdirect' pathway. Neurosci. Res. 2002, 43(2):111-117.
43. Obeso J., Group D-BSfPsDS Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N. Engl. J. Med. 2001, 345(13):956-963.
44. Okun M.S., Vitek J.L. Lesion therapy for Parkinson's disease and other movement disorders: update and controversies. Mov. Disord. 2004, 19(4):375-389.
45. Ostrem J.L., Racine C.A., Glass G.A., Grace J.K., Volz M.M., Heath S.L., et al. Subthalamic nucleus deep brain stimulation in primary cervical dystonia. Neurology 2011, 76(10):870-878.
46. Padberg J., Recanzone G., Engle J., Cooke D., Goldring A., Krubitzer L. Lesions in posterior parietal area 5 in monkeys result in rapid behavioral and cortical plasticity. J. Neurosci. 2010, 30(39):12918-12935.
47. Patel N.K., Heywood P., O'Sullivan K., McCarter R., Love S., Gill S.S. Unilateral subthalamotomy in the treatment of Parkinson's disease. Brain 2003, 126(Pt. 5):1136-1145.
48. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1986, Academic Press, New York.
49. Plenz D., Kital S.T. A basal ganglia pacemaker formed by the subthalamic nucleus and external globus pallidus. Nature 1999, 400(6745):677-682.
50. Robertson G.S., Matsumura H., Fibiger H.C. Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. J. Pharmacol. Exp. Ther. 1994, 271(2):1058-1066.
51. Schrader C., Peschel T., Petermeyer M., Dengler R., Hellwig D. Unilateral deep brain stimulation of the internal globus pallidus alleviates tardive dyskinesia. Mov. Disord. 2004, 19(5):583-585.
52. Schulte T., Brecht S., Herdegen T., Illert M., Mehdorn H.M., Hamel W. Induction of immediate early gene expression by high-frequency stimulation of the subthalamic nucleus in rats. Neuroscience 2006, 138(4):1377-1385.
53. Su P.C., Ma Y., Fukuda M., Mentis M.J., Tseng H.M., Yen R.F., et al. Metabolic changes following subthalamotomy for advanced Parkinson's disease. Ann. Neurol. 2001, 50(4):514-520.
54. Sun B., Chen S., Zhan S., Le W., Krahl S.E. Subthalamic nucleus stimulation for primary dystonia and tardive dystonia. Acta Neurochir. Suppl. 2007, 97(Pt. 2):207-214.
55. Szymanski S., Gur R.C., Gallacher F., Mozley L.H., Gur R.E. Vulnerability to tardive dyskinesia development in schizophrenia: an FDG-PET study of cerebral metabolism. Neuropsychopharmacology 1996, 15(6):567-575.
56. Tamminga C.A., Dale J.M., Goodman L., Kaneda H., Kaneda N. Neuroleptic-induced vacuous chewing movements as an animal model of tardive dyskinesia: a study in three rat strains. Psychopharmacology (Berl) 1990, 102:474-478.
57. Turrone P., Remington G., Nobrega J.N. The vacuous chewing movement (VCM) model of tardive dyskinesia revisited: is there a relationship to dopamine D(2) receptor occupancy?. Neurosci. Biobehav. Rev. 2002, 26(3):361-380.
58. Vita A., De Peri L. The effects of antipsychotic treatment on cerebral structure and function in schizophrenia. Int. Rev. Psychiatry 2007, 19(4):429-436.
59. Vitek J.L., Bakay R.A., Freeman A., Evatt M., Green J., McDonald W., et al. Randomized trial of pallidotomy versus medical therapy for Parkinson's disease. Ann. Neurol. 2003, 53(5):558-569.
60. Volkmann J., Albanese A., Kulisevsky J., Tornqvist A.L., Houeto J.L., Pidoux B., et al. Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease. Mov. Disord. 2009, 24(8):1154-1161.
61. Waddington J.L., O'Callaghan E., Buckley P., Madigan C., Redmond O., Stack J.P., et al. Tardive dyskinesia in schizophrenia. Relationship to minor physical anomalies, frontal lobe dysfunction and cerebral structure on magnetic resonance imaging. Br. J. Psychiatry 1995, 167(1):41-44.
62. Wallace B.A., Ashkan K., Heise C.E., Foote K.D., Torres N., Mitrofanis J., et al. Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeys. Brain 2007, 130(Pt. 8):2129-2145.
63. Wang Y., Turnbull I., Calne S., Stoessl A.J., Calne D.B. Pallidotomy for tardive dyskinesia. Lancet 1997, 349(9054):777-778.
64. Zhang J.G., Zhang K., Wang Z.C., Ge M., Ma Y. Deep brain stimulation in the treatment of secondary dystonia. Chin. Med. J. (Engl) 2006, 119(24):2069-2074.